Bio-Restorative Therapies chief medical advisor, spine medicine Stem-cell technology company Bio-Restorative Therapies Inc. named Gregory Lutz chief medical advisor for spine medicine, effective Feb
Device Transactions Although medical device companies had a strong opening in 2012 — they brought in $1.1 billion in Q1— the second quarter saw a dip in the money raised. While it is certainly a respe
Medical Device Transactions Medical device companies raised $800 million in the fourth quarter, bringing the total 2011 funding for this industry to $4.1 billion, up 28% from 2010’s $3.2 billion. This
IN VITRO DIAGNOSTICS Alliances AEterna Zentaris Inc. Roche Ventana Medical Systems Inc. In one of two companion diagnostics deals it signed on the same day, Roche Diagnostics Corp. ’s Ventana Med